Changsheng Du

Putuo People's Hospital, Tongji University

Research Area

Biography

Changsheng Du has not added Biography.
If you are Changsheng Du and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 2	2022

Other Publications

Article	Year
Antiasthmatic drugs targeting the cysteinyl leukotriene receptor 1 alleviate central nervous system inflammatory cell infiltration and pathogenesis of experimental autoimmune encephalomyelit... Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 21804021	2011
G protein-coupled receptors as therapeutic targets for multiple sclerosis. Cell research\| PubMed ID: 22664908	2012
The antiepileptic drug valproic acid restores T cell homeostasis and ameliorates pathogenesis of experimental autoimmune encephalomyelitis. The Journal of biological chemistry\| PubMed ID: 22733814	2012
Blocking A2B adenosine receptor alleviates pathogenesis of experimental autoimmune encephalomyelitis via inhibition of IL-6 production and Th17 differentiation. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 23225885	2013
Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination. Nature communications\| PubMed ID: 27040771	2016
The Spatio-Temporal Expression Profiles of CD4 + T Cell Differentiation and Function-Related Genes During EAE Pathogenesis. Inflammation\| PubMed ID: 27882475	2017
A betulinic acid derivative SH479 inhibits collagen-induced arthritis by modulating T cell differentiation and cytokine balance. Biochemical pharmacology\| PubMed ID: 27965071	2017
SH479, a Betulinic Acid Derivative, Ameliorates Experimental Autoimmune Encephalomyelitis by Regulating the T Helper 17/Regulatory T Cell Balance. Molecular pharmacology\| PubMed ID: 28213589	2017
Deficiency of the G protein Gαq ameliorates experimental autoimmune encephalomyelitis with impaired DC-derived IL-6 production and Th17 differentiation. Cellular & molecular immunology\| PubMed ID: 28216651	2017
Discovery of BVDU as a promising Drug for autoimmune diseases Therapy by Dendritic-cell-based functional screening. Scientific reports\| PubMed ID: 28272439	2017
Critical Role of P2Y Receptor in Regulation of Th17 Differentiation and Experimental Autoimmune Encephalomyelitis Pathogenesis. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 28515278	2017
Betaine Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Dendritic Cell-Derived IL-6 Production and Th17 Differentiation. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 29330324	2018
BLT1 in dendritic cells promotes Th1/Th17 differentiation and its deficiency ameliorates TNBS-induced colitis. Cellular & molecular immunology\| PubMed ID: 29670278	2018
Deficiency of β-Arrestin 2 in Dendritic Cells Contributes to Autoimmune Diseases. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 30541881	2019
The novel small-molecule TPN10456 inhibits Th17 cell differentiation and protects against experimental autoimmune encephalomyelitis. Cellular & molecular immunology\| PubMed ID: 33110252	2020
9,10-Anhydrodehydroartemisinin Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Th1 and Th17 Cell Differentiation. Inflammation\| PubMed ID: 33788130	2021
Methyl Butyrate Alleviates Experimental Autoimmune Encephalomyelitis and Regulates the Balance of Effector T Cells and Regulatory T Cells. Inflammation\| PubMed ID: 34786625	2022
Methyl acetate arrests Th1 in peripheral immune system and alleviates CNS inflammation in EAE. International immunopharmacology\| PubMed ID: 34799286	2021
Sin3a drives mesenchymal-to-epithelial transition through cooperating with Tet1 in somatic cell reprogramming. Stem cell research & therapy\| PubMed ID: 35073971	2022
Artemisinin derivative TPN10466 suppresses immune cell migration and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis. Cellular immunology\| PubMed ID: 35276582	2022
Chlorzoxazone Alleviates Experimental Autoimmune Encephalomyelitis via Inhibiting IL-6 Secretion of Dendritic Cells. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 35277421	2022
Synthesis and biological evaluation of artemisinin derivatives as potential MS agents. Bioorganic & medicinal chemistry letters\| PubMed ID: 35304225	2022
Amelioration of Experimental Autoimmune Encephalomyelitis in Alzheimer's Disease Mouse Models: A Potential Role for Aβ. Cells\| PubMed ID: 35326455	2022